We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+20.94%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$612B
AUM Growth
+$90.2B
Cap. Flow
+$5B
Cap. Flow %
0.82%
Top 10 Hldgs %
32.09%
Holding
12,204
New
1,722
Increased
4,580
Reduced
4,534
Closed
1,264

Top Sells

Rank Stock Value
1
C icon
Citigroup
C
+$703M
2
BAC icon
Bank of America
BAC
+$690M
3
AMZN icon
Amazon
AMZN
+$678M
4
JPM icon
JPMorgan Chase
JPM
+$601M
5
META icon
Meta Platforms (Facebook)
META
+$431M

Sector Composition

Rank Sector Weight
1 Miscellaneous 92.11%
2 Technology 2.38%
3 Consumer Discretionary 1.48%
4 Healthcare 0.92%
5 Communication Services 0.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPSS icon
10526
CALL
Consumer Portfolio Services
CPSS
$202M
$79K ﹤0.01%
+18,700
New +$75.4K
CPSS icon
10527
Consumer Portfolio Services
CPSS
$202M
$79K ﹤0.01%
18,624
-23,353
-56% -$94.2K
DYAI icon
10528
CALL
Dyadic International
DYAI
$25.6M
$79K ﹤0.01%
14,700
-16,300
-53% -$107K
KZR
10529
DELISTED
Kezar Life Sciences
KZR
$79K ﹤0.01%
1,513
-144
-9% -$8.01K
OXLC
10530
Oxford Lane Capital
OXLC
$944M
$79K ﹤0.01%
+2,934
New +$72.3K
PPBT
10531
Purple Biotech
PPBT
$2.7M
$79K ﹤0.01%
+103
New +$86.8K
ULBI icon
10532
Ultralife
ULBI
$108M
$79K ﹤0.01%
+12,134
New +$76.6K
VIRX
10533
CALL
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$79K ﹤0.01%
11,286
-3,714
-25% -$19.4K
TTOO
10534
PUT
DELISTED
T2 Biosystems, Inc
TTOO
$79K ﹤0.01%
13
+8
+160% +$49K
AUTO
10535
DELISTED
AutoWeb, Inc. Common Stock
AUTO
$79K ﹤0.01%
+31,899
New +$98.8K
ADVWW
10536
DELISTED
Advantage Solutions Warrant
ADVWW
$78K ﹤0.01%
+27,367
New +$54.1K
CRVS icon
10537
PUT
Corvus Pharmaceuticals
CRVS
$1.24B
$78K ﹤0.01%
+21,900
New +$88.2K
TCDA
10538
CALL
DELISTED
Tricida, Inc. Common Stock
TCDA
$78K ﹤0.01%
+11,000
New +$84.4K
AQMS icon
10539
PUT
Aqua Metals
AQMS
$9.99M
$77K ﹤0.01%
+128
New +$31.7K
EEX
10540
DELISTED
Emerald Holding
EEX
$77K ﹤0.01%
+14,198
New +$52.6K
GYRE icon
10541
Gyre Therapeutics
GYRE
$708M
$77K ﹤0.01%
+1,623
New +$70.3K
RLGT icon
10542
Radiant Logistics
RLGT
$408M
$77K ﹤0.01%
13,231
+573
+5% +$3.2K
SCYX icon
10543
PUT
SCYNEXIS
SCYX
$54.9M
$77K ﹤0.01%
+1,263
New +$59.2K
SIGA icon
10544
SIGA Technologies
SIGA
$220M
$77K ﹤0.01%
10,624
+464
+5% +$3.27K
PRTK
10545
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$77K ﹤0.01%
12,344
-64,678
-84% -$381K
OPENW
10546
DELISTED
Opendoor Technologies Inc Warrants expiring 12/18/2025
OPENW
$77K ﹤0.01%
10,000
SVVC
10547
CALL
DELISTED
Firsthand Technology Value Fund, Inc. Common Stock
SVVC
$76K ﹤0.01%
17,000
-27,000
-61% -$106K
RBAC.WS
10548
DELISTED
RedBall Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordina
RBAC.WS
$76K ﹤0.01%
+34,007
New +$61.4K
LPTH icon
10549
Lightpath Technologies
LPTH
$866M
$75K ﹤0.01%
+19,053
New +$54.9K
SLNO
10550
DELISTED
Soleno Therapeutics
SLNO
$75K ﹤0.01%
2,582
+105
+4% +$3.03K

Similar funds

Jeff Yass's Q4 2020 Portfolio in Review

As of Q4 2020, Jeff Yass held 12,204 positions worth $612B, up 17% from $522B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Jeff Yass's Q4 2020 filing shows 1,722 new, 4,580 increased, 4,534 reduced and 1,264 closed positions. Its largest new stake was International Flavors & Fragrances: 726,729 shares worth $79.1M. The largest sale was Citigroup, an estimated $703M.

By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, down from 93% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q4 2020 buy was International Flavors & Fragrances: 726,729 shares worth $79.1M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $1.46B increase.
  • Jeff Yass's biggest Q4 2020 reduction was Citigroup, cutting an estimated $703M.
  • Jeff Yass fully exited Vanguard Total International Bond ETF in Q4 2020, selling an estimated $146M.
  • Jeff Yass's ten largest holdings make up 32% of its $612B portfolio in Q4 2020.
  • Jeff Yass opened 1,722 new positions and closed 1,264 in Q4 2020.
  • Jeff Yass's portfolio value rose 17% quarter-over-quarter to $612B.

Based on Susquehanna International Group's 13F filing for Q4 2020, filed 16 Feb 2021.